What Is Addiction? History, Terminology, and Core Concepts.
Olsen Y.
Med Clin North Am. 2022 Jan;106(1):1-12. doi: 10.1016/j.mcna.2021.08.001.
Risk Factors for Opioid-Use Disorder and Overdose.
Webster LR.
Anesth Analg. 2017 Nov;125(5):1741-1748. doi: 10.1213/ANE.0000000000002496.
The neurobiology of opioid dependence: implications for treatment.
Kosten TR, George TP.
Sci Pract Perspect. 2002 Jul;1(1):13-20. doi: 10.1151/spp021113.
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.
Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN.
Pain. 2015 Apr;156(4):569-576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
How addictive are gabapentin and pregabalin? A systematic review.
Bonnet U, Scherbaum N.
Eur Neuropsychopharmacol. 2017 Dec;27(12):1185-1215. doi: 10.1016/j.euroneuro.2017.08.430. Epub 2017 Oct 5.
[Addictions].
Vogel M, Strasser H, Thorens G, Zullino D, Humair JP, Simon O, Broers B, Haettel C, Devaud C, Gothuey I, Favrod-Counej T, Daeppen JB.
Rev Med Suisse. 2020 Jan 15;16(676-7):8-11.
[Heroin addiction].
Hosztafi S.
Acta Pharm Hung. 2011;81(4):173-83.
Addiction and the cerebellum with a focus on actions of opioid receptors.
Ranjbar H, Soti M, Banazadeh M, Saleki K, Kohlmeier KA, Shabani M.
Neurosci Biobehav Rev. 2021 Dec;131:229-247. doi: 10.1016/j.neubiorev.2021.09.021. Epub 2021 Sep 20.
Opiates and plasticity.
Dacher M, Nugent FS.
Neuropharmacology. 2011 Dec;61(7):1088-96. doi: 10.1016/j.neuropharm.2011.01.028. Epub 2011 Jan 25.
Current status of immunotherapies for addiction.
Xu A, Kosten TR.
Ann N Y Acad Sci. 2021 Apr;1489(1):3-16. doi: 10.1111/nyas.14329. Epub 2020 Mar 8.
